Overview

Diabetes poses a significant challenge to healthcare providers across the country. Its management requires a thorough understanding of the complex nature of the disease and its relationship with associated conditions such as obesity and cardiovascular disease. Successful management of diabetes requires early identification of risk factors, prevention of progression to disease, attention to comorbidities, and utilization of evidence-based clinical strategies to address specific aspects and presentations of disease. 

The primary aim of this integrated, multi-interventional curriculum is to provide clinicians at the front-lines of this epidemic with tools to better prevent, diagnose, and manage diabetes and related illnesses in order to improve patient care.   


Learning Objectives

  • Identify and screen individuals at risk for developing diabetes in order to increase early diagnosis and intervention, particularly among populations at greatest risk for diabetes and comorbid disease. 
  • Apply updated evidence-based guideline strategies to screen and treat obesity in patients with diabetes, while considering clinical, ethnic, and cultural factors that may impact management 
  • Develop guideline-based treatment goals that best meet the individual needs of patients with diabetes and cardiometabolic issues, in order to reduce risks and improve patient health outcomes 
  • Distinguish among available, newly approved, and emerging diabetes therapies, used alone or in combination with other antihyperglycemic agents, with regard to efficacy and safety, in order to help clinicians appropriately establish treatment regimens that best manage glycemic challenges, mitigate cardiometabolic issues, and achieve therapeutic goals 
  • Implement individualized, evidence-based strategies to overcome barriers to injectable therapies in order to initiate and intensify injectable therapies in patients who fail to meet therapeutic goals 
  • Apply current evidence and proven clinical strategies to reduce comorbid cardiovascular risks and complications of diabetes, including hypertension, dyslipidemia, and coronary artery disease 


Courses

Commercial Supporters

Boehringer Ingelheim Pharmaceuticals, Inc., and Lilly USA, LLC.; Novo Nordisk Inc.; and Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Education Partners

pmiCME 


Fine Print

Internet Explorer (version 9.0 and above) is the minimum supported browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

Internet Explorer (version 9.0 and above) is the minimum supported browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

pmiCME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of pmiCME to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

pmiCME Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. pmiCME, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. pmiCME is the accredited provider for this activity.

Disclosures and Conflict of Interest
pmiCME requires all individuals in a position to influence educational content for pmiCME-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. pmiCME assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by pmiCME or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.